Cannara Biotech (OTCMKTS:CNBTF – Get Free Report)’s stock price was down 0.9% on Thursday. The stock traded as low as $1.4670 and last traded at $1.4670. Approximately 300 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 33,127 shares. The stock had previously closed at $1.48.
Cannara Biotech Price Performance
The stock has a 50-day simple moving average of $1.46 and a 200-day simple moving average of $1.34.
Cannara Biotech Inc is a Canadian cannabis company that cultivates, manufactures and distributes cannabis products for the adult-use and medical markets. The company operates from Quebec and focuses on producing indoor-grown cannabis in a controlled environment.
Cannara’s product portfolio includes dried flower, pre-rolls, vape products, concentrates and other cannabis formats. Its consumer brands include Tribal, Nugz and Orchid CBD, which are marketed through authorized provincial cannabis distribution systems and retailers.
The company’s operations are centered on its cultivation and processing facilities in Quebec, supporting sales primarily in Canadian markets where its products are authorized for distribution.
Featured Articles
- Five stocks we like better than Cannara Biotech
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
